Navigation Links
Study Warns of Kidney Damage Risk with Popular Mesothelioma Drug, Reports Surviving Mesothelioma

Raleigh, NC (PRWEB) July 16, 2014

Italian scientists say patients on the popular mesothelioma drug pemetrexed may need to take certain precautions to avoid damaging their kidneys. An article on the new research has just been published on the Surviving Mesothelioma website. Click here to read it now.

Kidney specialists at St. Andrea Hospital in La Spezia analyzed the treatment records of 38 patients with non-small cell lung cancer who developed acute kidney injuries after treatment with pemetrexed. The problems occurred in 21% of patients, even though their baseline kidney function tests (eGFR) met the recommended levels for pemetrexed treatment.

“There is no clear cut eGFR above which pemetrexed may be used without potential risks of renal toxicity. If pemetrexed has to be used, all the coexisting risk factors for AKI should be possibly corrected,” concludes lead investigator, Giuseppe Rombola.

Pemetrexed, along with surgery and/or radiation, is a leading treatment for malignant mesothelioma, an asbestos-linked cancer with no known cure.

“This news is potentially significant for mesothelioma patients because so many of them are on or will be on pemetrexed,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “It sends a message that the potential for kidney damage should not be ignored, even among patients who do not appear to be at high risk.”

To read the details of the new study and its possible implications for mesothelioma patients, see Kidney Risk May be Unavoidable with Top Mesothelioma Drug, now available on the Surviving Mesothelioma website.

Rombola, G, et al, “Pemetrexed induced acute kidney injury in patients with non-small cell lung cancer: reversible and chronic renal damage”, June 23, 2014, Journal of Nephrology,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology: